Clinical parameters assessed were overall survival (OS), progression free survival (PFS), time to progression (TTP) grade, age, and tumor stage at first diagnosis, presence of peritoneal carcinomatosis, lymph node or distant metastases, platinum sensitivity, and PDL1 expression. Here, CD274 is linked to neoplasm.